Reversible Diffusion-Weighted Imaging Lesions in Acute Ischemic Stroke
Neurol 94:571-587, Nagaraja, N.,et al, 2020
Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017
Evidence-Based Guideline: The Role of Diffusion and Perfusion MRI for the Diagnosis of Acute Ischemic Stroke: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 75:177-185, Schellinger,P.D., et al, 2010
No-Go to Tissue Plasminogen Activator for Transient Ischemic Attack
Stroke 41:3005-3006, 3007, Liebeskind,D.S., 2010
Pro: Intravenous Tissue Plasminogen Activator in Stroke Patients With Rapid, Complete Recovery During Evaluation (Transient Ischemic Attack) and Evidence of Middle Cerebral Artery Occlusion
Stroke 41:3003-3004, 3007, K�hrmann,M. &Schellinger,P.D., 2010
Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008
Intra-arterial Therapies for Acute Ischemic Stroke
Neurol 68:2132-2139, Mandava,P. &Kent,T.A., 2007
Conjugate Eye Deviation in Acute Stroke: Incidence, Hemispheric Asymmetry, and Lesion Pattern
Stroke 37:2726-2732, Singer,O.C.,et al, 2006
Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001